Consolidated Quarterly Holdings Report
for
Fidelity® Growth Company Fund
August 31, 2026
GCF-NPRT3-1026
1.805820.122
Common Stocks - 97.9%
 
 
Shares
Value ($)
 
ARGENTINA - 0.0%
 
 
 
Energy - 0.0%
 
 
 
Oil, Gas & Consumable Fuels - 0.0%
 
 
 
Vista Energy SAB de CV ADR (b)(g)
 
128,741
9,199,832
BELGIUM - 0.8%
 
 
 
Health Care - 0.8%
 
 
 
Biotechnology - 0.7%
 
 
 
Argenx SE ADR (b)
 
608,314
627,573,221
Neurona Therapeutics Inc (d)(f)
 
3,297,200
98,916
Neurona Therapeutics Inc (d)(f)
 
3,297,200
33
Neurona Therapeutics Inc escrow shares (d)(f)
 
3,297,200
494,580
Neurona Therapeutics Inc milestone 1 rights (b)(f)
 
3,297,200
989,160
Neurona Therapeutics Inc milestone 2 rights (b)(d)(f)
 
3,297,200
32,972
Neurona Therapeutics Inc milestone 3 rights (b)(d)(f)
 
3,297,200
32,972
Neurona Therapeutics Inc milestone 4 rights (b)(d)(f)
 
3,297,200
32,972
 
 
 
629,254,826
Pharmaceuticals - 0.1%
 
 
 
AgomAb Therapeutics NV ADR (i)
 
958,312
12,620,969
AgomAb Therapeutics NV ADR (g)
 
507,250
6,680,483
UCB SA
 
332,623
83,182,930
 
 
 
102,484,382
TOTAL BELGIUM
 
 
731,739,208
CANADA - 0.5%
 
 
 
Consumer Discretionary - 0.0%
 
 
 
Textiles, Apparel & Luxury Goods - 0.0%
 
 
 
Canada Goose Holdings Inc Subordinate Voting Shares (b)
 
1,243,851
10,276,051
Energy - 0.1%
 
 
 
Oil, Gas & Consumable Fuels - 0.1%
 
 
 
Cameco Corp (United States)
 
785,949
77,620,323
Health Care - 0.0%
 
 
 
Pharmaceuticals - 0.0%
 
 
 
InMed Pharmaceuticals Inc (c)(d)(e)(f)
 
6,610,051
17,847,138
Information Technology - 0.2%
 
 
 
Electronic Equipment, Instruments & Components - 0.0%
 
 
 
Celestica Inc (United States) (b)
 
43,554
13,040,068
IT Services - 0.2%
 
 
 
Shopify Inc Class A (b)
 
863,367
127,248,441
Software - 0.0%
 
 
 
Taalas Inc warrants (b)(d)(f)
 
1,768,822
7,340,611
TOTAL INFORMATION TECHNOLOGY
 
 
147,629,120
Materials - 0.2%
 
 
 
Metals & Mining - 0.2%
 
 
 
Agnico Eagle Mines Ltd/CA (United States) (g)
 
283,470
57,575,592
Franco-Nevada Corp (United States)
 
147,641
38,851,729
Kinross Gold Corp (United States)
 
764,775
23,463,297
Novagold Resources Inc (United States) (b)(g)
 
4,139,683
35,601,274
TOTAL MATERIALS
 
 
155,491,892
TOTAL CANADA
 
 
408,864,524
CHINA - 0.1%
 
 
 
Consumer Discretionary - 0.1%
 
 
 
Automobiles - 0.0%
 
 
 
BYD Co Ltd H Shares
 
2,532,300
27,951,143
Hotels, Restaurants & Leisure - 0.1%
 
 
 
Atour Lifestyle Holdings Ltd ADR
 
633,165
22,148,112
Luckin Coffee Inc ADR (b)
 
1,917,693
68,845,179
 
 
 
90,993,291
TOTAL CONSUMER DISCRETIONARY
 
 
118,944,434
Financials - 0.0%
 
 
 
Financial Services - 0.0%
 
 
 
Ant International Co Ltd Class C (d)(f)
 
1,755,314
2,790,949
Health Care - 0.0%
 
 
 
Biotechnology - 0.0%
 
 
 
Zai Lab Ltd ADR (b)(g)
 
331,780
8,447,119
TOTAL CHINA
 
 
130,182,502
DENMARK - 0.0%
 
 
 
Health Care - 0.0%
 
 
 
Biotechnology - 0.0%
 
 
 
Ascendis Pharma A/S (b)
 
54,094
14,228,886
Zealand Pharma A/S (b)
 
560,703
26,138,172
 
 
 
40,367,058
Pharmaceuticals - 0.0%
 
 
 
Novo Nordisk A/S Class B ADR
 
20,397
924,596
TOTAL DENMARK
 
 
41,291,654
FINLAND - 0.1%
 
 
 
Consumer Discretionary - 0.0%
 
 
 
Textiles, Apparel & Luxury Goods - 0.0%
 
 
 
Amer Sports Inc (b)
 
447,161
13,660,769
Information Technology - 0.1%
 
 
 
Communications Equipment - 0.1%
 
 
 
Nokia Oyj ADR
 
6,270,166
63,579,483
TOTAL FINLAND
 
 
77,240,252
FRANCE - 0.0%
 
 
 
Health Care - 0.0%
 
 
 
Biotechnology - 0.0%
 
 
 
Abivax SA ADR (b)(g)
 
37,334
4,171,328
Health Care Technology - 0.0%
 
 
 
DNA Script SAS (b)(d)(f)
 
463
2,732
DNA Script SAS seed shares (b)(d)(f)
 
1,769
10,459
 
 
 
13,191
Pharmaceuticals - 0.0%
 
 
 
Kartos Therapeutics Inc 250M Milestone rights (b)(d)(f)
 
1,806,457
18
Kartos Therapeutics Inc 950M Milestone rights (b)(d)(f)
 
1,806,457
5,455,500
Kartos Therapeutics Inc Representative Escrow rights (b)(f)
 
1,806,457
18
 
 
 
5,455,536
TOTAL FRANCE
 
 
9,640,055
GERMANY - 0.0%
 
 
 
Consumer Discretionary - 0.0%
 
 
 
Textiles, Apparel & Luxury Goods - 0.0%
 
 
 
Adidas AG
 
2,526
442,422
Birkenstock Holding Plc (b)(g)
 
9,992
348,820
TOTAL CONSUMER DISCRETIONARY
 
 
791,242
Health Care - 0.0%
 
 
 
Biotechnology - 0.0%
 
 
 
BioNTech SE ADR (b)
 
99,878
10,148,604
TOTAL GERMANY
 
 
10,939,846
INDIA - 0.2%
 
 
 
Consumer Discretionary - 0.2%
 
 
 
Broadline Retail - 0.1%
 
 
 
Meesho (b)
 
33,305,674
71,880,132
Meesho (b)
 
187,290
404,208
 
 
 
72,284,340
Hotels, Restaurants & Leisure - 0.1%
 
 
 
Eternal Ltd (b)
 
9,483,800
32,696,401
MakeMyTrip Ltd (b)(g)
 
355,577
20,715,916
 
 
 
53,412,317
Specialty Retail - 0.0%
 
 
 
Lenskart Solutions Ltd (b)
 
160,688
1,118,446
TOTAL CONSUMER DISCRETIONARY
 
 
126,815,103
Energy - 0.0%
 
 
 
Oil, Gas & Consumable Fuels - 0.0%
 
 
 
Reliance Industries Ltd
 
1,524,376
20,454,758
Financials - 0.0%
 
 
 
Banks - 0.0%
 
 
 
HDFC Bank Ltd ADR
 
271,534
6,163,822
Financial Services - 0.0%
 
 
 
Jio Financial Services Ltd
 
2,318,738
5,880,447
TOTAL FINANCIALS
 
 
12,044,269
Industrials - 0.0%
 
 
 
Air Freight & Logistics - 0.0%
 
 
 
Delhivery Ltd (b)
 
2,269,100
10,877,278
TOTAL INDIA
 
 
170,191,408
IRELAND - 0.1%
 
 
 
Health Care - 0.1%
 
 
 
Biotechnology - 0.0%
 
 
 
Prothena Corp PLC (b)
 
2,185,075
20,430,451
Pharmaceuticals - 0.1%
 
 
 
GH Research PLC (b)
 
1,935,309
52,214,637
TOTAL IRELAND
 
 
72,645,088
ISRAEL - 0.0%
 
 
 
Consumer Staples - 0.0%
 
 
 
Personal Care Products - 0.0%
 
 
 
Oddity Tech Ltd Class A (b)(g)
 
454,876
6,550,214
Information Technology - 0.0%
 
 
 
Semiconductors & Semiconductor Equipment - 0.0%
 
 
 
Xsight Labs Ltd warrants 7/24/2032 (b)(d)(f)
 
391,041
3,183,074
TOTAL ISRAEL
 
 
9,733,288
ITALY - 0.0%
 
 
 
Industrials - 0.0%
 
 
 
Passenger Airlines - 0.0%
 
 
 
Ryanair Holdings PLC ADR
 
54,199
3,000,999
Information Technology - 0.0%
 
 
 
Software - 0.0%
 
 
 
Bending Spoons SpA (d)(h)
 
276,000
11,412,600
Bending Spoons SpA (b)(g)
 
62,000
2,563,700
TOTAL INFORMATION TECHNOLOGY
 
 
13,976,300
TOTAL ITALY
 
 
16,977,299
JAPAN - 0.2%
 
 
 
Consumer Discretionary - 0.0%
 
 
 
Broadline Retail - 0.0%
 
 
 
Rakuten Group Inc (b)(g)
 
446,826
2,157,339
Industrials - 0.0%
 
 
 
Machinery - 0.0%
 
 
 
Mitsubishi Heavy Industries Ltd
 
1,989,745
48,216,484
Information Technology - 0.2%
 
 
 
Semiconductors & Semiconductor Equipment - 0.2%
 
 
 
Allegro MicroSystems Inc (b)
 
560,194
20,307,032
Kioxia Holdings Corp (b)
 
374,806
115,887,773
TOTAL INFORMATION TECHNOLOGY
 
 
136,194,805
TOTAL JAPAN
 
 
186,568,628
KOREA (SOUTH) - 0.0%
 
 
 
Information Technology - 0.0%
 
 
 
Technology Hardware, Storage & Peripherals - 0.0%
 
 
 
Samsung Electronics Co Ltd
 
213,505
40,599,507
MEXICO - 0.0%
 
 
 
Consumer Staples - 0.0%
 
 
 
Consumer Staples Distribution & Retail - 0.0%
 
 
 
BBB Foods Inc Class A (b)
 
969,922
47,109,112
NETHERLANDS - 0.1%
 
 
 
Health Care - 0.1%
 
 
 
Pharmaceuticals - 0.1%
 
 
 
Pharvaris NV (b)
 
1,373,193
47,526,210
Information Technology - 0.0%
 
 
 
Semiconductors & Semiconductor Equipment - 0.0%
 
 
 
ASML Holding NV depository receipt
 
17,710
30,036,337
TOTAL NETHERLANDS
 
 
77,562,547
RUSSIA - 0.0%
 
 
 
Consumer Discretionary - 0.0%
 
 
 
Broadline Retail - 0.0%
 
 
 
Ozon Holdings PLC ADR (b)(f)(g)
 
100
0
SWITZERLAND - 0.3%
 
 
 
Consumer Discretionary - 0.1%
 
 
 
Textiles, Apparel & Luxury Goods - 0.1%
 
 
 
On Holding AG Class A (b)
 
3,432,084
97,814,394
Health Care - 0.2%
 
 
 
Biotechnology - 0.1%
 
 
 
CRISPR Therapeutics AG (b)(g)
 
592,327
33,750,793
Idorsia Ltd (b)(g)
 
5,149,958
31,472,496
 
 
 
65,223,289
Pharmaceuticals - 0.1%
 
 
 
Galderma Group AG
 
267,155
55,395,185
TOTAL HEALTH CARE
 
 
120,618,474
Information Technology - 0.0%
 
 
 
Electronic Equipment, Instruments & Components - 0.0%
 
 
 
TE Connectivity PLC
 
11,492
2,358,733
TOTAL SWITZERLAND
 
 
220,791,601
TAIWAN - 0.2%
 
 
 
Information Technology - 0.2%
 
 
 
Semiconductors & Semiconductor Equipment - 0.2%
 
 
 
Taiwan Semiconductor Manufacturing Co Ltd ADR
 
514,748
213,785,139
UNITED KINGDOM - 0.1%
 
 
 
Consumer Staples - 0.1%
 
 
 
Personal Care Products - 0.0%
 
 
 
Unilever PLC ADR
 
21,973
1,424,949
Tobacco - 0.1%
 
 
 
British American Tobacco PLC ADR
 
1,018,686
56,608,382
TOTAL CONSUMER STAPLES
 
 
58,033,331
Energy - 0.0%
 
 
 
Energy Equipment & Services - 0.0%
 
 
 
TechnipFMC PLC
 
246,588
19,270,852
Financials - 0.0%
 
 
 
Financial Services - 0.0%
 
 
 
Revolut Group Holdings Ltd (b)(d)(f)
 
13,544
26,125,563
Health Care - 0.0%
 
 
 
Biotechnology - 0.0%
 
 
 
Immunocore Holdings PLC ADR (b)
 
625,423
22,715,363
Industrials - 0.0%
 
 
 
Electrical Equipment - 0.0%
 
 
 
DPC Holdings PLC
 
139,428
5,850,399
TOTAL UNITED KINGDOM
 
 
131,995,508
UNITED STATES - 95.2%
 
 
 
Communication Services - 15.9%
 
 
 
Diversified Telecommunication Services - 3.6%
 
 
 
Comcast Corp Class A
 
295,824
7,874,835
Lumen Technologies Inc (b)
 
12,426,991
77,668,694
Space Exploration Technologies Corp (h)
 
2,654,578
362,364,497
Space Exploration Technologies Corp - 180 Day Lockup Final Release (h)
 
993,831
142,803,576
Space Exploration Technologies Corp - Lockup Released
 
867,642
118,437,905
Space Exploration Technologies Corp - October 24, 2026 Lockup Release (h)
 
1,502,284
215,863,188
Space Exploration Technologies Corp - October 9, 2026 Lockup Release (h)
 
1,502,284
215,863,188
Space Exploration Technologies Corp - Q3 2026 Earnings Release Lockup (h)
 
6,009,138
820,280,387
Space Exploration Technologies Corp - September 24, 2026 Lockup Release (h)
 
1,502,284
215,863,188
Space Exploration Technologies Corp - September 9, 2026 Lockup Release (h)
 
1,502,284
215,863,188
Space Exploration Technologies Corp Class A (g)
 
7,871,625
1,131,073,797
 
 
 
3,523,956,443
Entertainment - 1.0%
 
 
 
Netflix Inc (b)
 
9,127,515
739,785,091
ROBLOX Corp Class A (b)
 
4,251,998
175,564,997
Spotify Technology SA (b)
 
80,028
43,504,821
Walt Disney Co/The
 
18,501
1,989,783
 
 
 
960,844,692
Interactive Media & Services - 10.8%
 
 
 
Alphabet Inc Class A
 
12,890,550
4,374,408,143
Alphabet Inc Class C
 
10,471,241
3,512,158,944
Epic Games Inc (b)(d)(f)
 
51,800
19,081,566
Meta Platforms Inc Class A
 
4,494,062
2,572,131,445
Reddit Inc Class B (b)
 
239,383
35,383,201
 
 
 
10,513,163,299
Media - 0.5%
 
 
 
AppLovin Corp Class A (b)
 
1,454,866
454,005,484
Trade Desk Inc (The) Class A (b)
 
9,995
137,130
Versant Media Group Inc Class A
 
11,832
486,532
 
 
 
454,629,146
TOTAL COMMUNICATION SERVICES
 
 
15,452,593,580
Consumer Discretionary - 7.9%
 
 
 
Automobiles - 1.1%
 
 
 
Rad Power Bikes Inc (b)(d)(f)
 
1,182,568
12
Rad Power Bikes Inc warrants 10/6/2033 (b)(d)(f)
 
985,838
10
Rivian Automotive Inc Class A (b)
 
1,570,470
25,221,748
Tesla Inc (b)
 
2,980,500
1,096,674,975
 
 
 
1,121,896,745
Broadline Retail - 3.4%
 
 
 
Amazon.com Inc (b)
 
11,999,146
3,117,018,157
Ollie's Bargain Outlet Holdings Inc (b)
 
2,300,301
173,488,701
 
 
 
3,290,506,858
Hotels, Restaurants & Leisure - 1.0%
 
 
 
Airbnb Inc Class A (b)
 
240,557
44,074,854
Booking Holdings Inc
 
1,180,266
234,979,158
Brinker International Inc (b)
 
837,489
191,366,237
Cava Group Inc (b)(g)
 
309,986
20,381,580
Chipotle Mexican Grill Inc (b)
 
1,882,007
71,572,726
DoorDash Inc Class A (b)
 
267,711
62,039,347
Dutch Bros Inc Class A (b)
 
295,634
14,444,677
Expedia Group Inc Class A
 
17,777
5,637,441
Hyatt Hotels Corp Class A (g)
 
143,369
23,938,322
Marriott International Inc/MD Class A1
 
405,530
138,593,933
McDonald's Corp
 
37,618
9,913,848
Shake Shack Inc Class A (b)
 
44,577
3,070,909
Starbucks Corp
 
1,183,469
125,743,581
Viking Holdings Ltd (b)
 
246,689
21,249,790
Wingstop Inc
 
76,749
8,402,481
Yum! Brands Inc
 
185,970
28,511,061
 
 
 
1,003,919,945
Household Durables - 0.4%
 
 
 
DR Horton Inc
 
138,872
20,075,336
Garmin Ltd
 
444,935
126,410,483
Lennar Corp Class A
 
43,092
3,624,468
SharkNinja Inc (b)
 
989,653
190,498,307
Somnigroup International Inc
 
160,327
10,381,173
Toll Brothers Inc
 
26,818
3,847,042
 
 
 
354,836,809
Specialty Retail - 1.8%
 
 
 
Carvana Co Class A (b)
 
1,147,713
84,310,997
Dick's Sporting Goods Inc
 
88,982
12,021,468
Fanatics Inc Class A (b)(d)(f)
 
730,532
74,864,919
Five Below Inc (b)
 
59,726
14,742,766
Floor & Decor Holdings Inc Class A (b)
 
388,604
19,535,123
Home Depot Inc/The
 
1,603,375
525,634,427
Lowe's Cos Inc
 
365,931
74,906,076
Revolve Group Inc Class A (b)
 
1,987,304
44,157,895
RH (b)
 
67,707
10,098,499
Ross Stores Inc
 
780,486
178,372,270
TJX Cos Inc/The
 
2,555,022
342,142,996
Wayfair Inc Class A (b)
 
4,289,774
425,845,865
 
 
 
1,806,633,301
Textiles, Apparel & Luxury Goods - 0.2%
 
 
 
Deckers Outdoor Corp (b)
 
922,839
80,360,820
Lululemon Athletica Inc (b)
 
172,228
20,712,139
NIKE Inc Class B
 
436,807
17,061,681
Tory Burch LLC Class A (b)(d)(f)(j)
 
950,844
35,533,040
Tory Burch LLC Class B (b)(d)(f)(j)
 
324,840
12,139,264
 
 
 
165,806,944
TOTAL CONSUMER DISCRETIONARY
 
 
7,743,600,602
Consumer Staples - 2.2%
 
 
 
Beverages - 0.8%
 
 
 
Celsius Holdings Inc (b)(g)
 
269,785
8,484,738
Coca-Cola Co/The
 
5,645,520
500,588,259
Constellation Brands Inc Class A
 
1,197
156,352
Keurig Dr Pepper Inc
 
1,617,618
51,537,309
Monster Beverage Corp (b)
 
1,901,946
87,337,361
PepsiCo Inc
 
310,494
43,574,728
 
 
 
691,678,747
Consumer Staples Distribution & Retail - 0.6%
 
 
 
Costco Wholesale Corp
 
368,324
347,657,341
Kroger Co/The
 
1,361,655
78,349,629
Maplebear Inc (b)
 
134,652
6,802,619
Sprouts Farmers Market Inc (b)
 
833,012
68,340,304
Target Corp
 
543,148
87,381,650
Walmart Inc
 
432,089
45,313,173
 
 
 
633,844,716
Food Products - 0.1%
 
 
 
Archer-Daniels-Midland Co
 
424,280
34,489,721
Bunge Global SA
 
315,442
36,657,515
Hershey Co/The
 
104,795
18,465,927
McCormick & Co Inc/MD
 
122,449
6,639,185
Mondelez International Inc
 
390,668
24,248,763
 
 
 
120,501,111
Household Products - 0.1%
 
 
 
Church & Dwight Co Inc
 
125,246
12,497,046
Clorox Co/The
 
34,928
3,411,767
Colgate-Palmolive Co
 
365,787
32,854,988
Procter & Gamble Co/The
 
284,212
41,244,846
 
 
 
90,008,647
Personal Care Products - 0.0%
 
 
 
Kenvue Inc
 
726,002
13,706,918
SkinHealth Systems Inc (b)(d)
 
2,438,817
1,648,883
 
 
 
15,355,801
Tobacco - 0.6%
 
 
 
JUUL Labs Inc Class A (b)(d)(f)
 
11,552,032
24,028,227
Philip Morris International Inc
 
3,263,354
611,226,204
 
 
 
635,254,431
TOTAL CONSUMER STAPLES
 
 
2,186,643,453
Energy - 0.4%
 
 
 
Energy Equipment & Services - 0.1%
 
 
 
Baker Hughes Co Class A
 
863,869
54,898,875
Halliburton Co
 
1,455,461
53,633,738
SLB Ltd
 
358,518
21,546,932
 
 
 
130,079,545
Oil, Gas & Consumable Fuels - 0.3%
 
 
 
EOG Resources Inc
 
239,016
34,647,759
EQT Corp
 
878,024
47,571,340
ExxonMobil Holdings Corp
 
105,484
16,977,650
Range Resources Corp
 
1,700,977
70,284,370
Valero Energy Corp
 
140,126
50,294,024
 
 
 
219,775,143
TOTAL ENERGY
 
 
349,854,688
Financials - 3.1%
 
 
 
Banks - 0.5%
 
 
 
Bank of America Corp
 
3,427,437
212,295,448
JPMorgan Chase & Co
 
434,706
154,764,030
US Bancorp
 
860,903
53,014,406
Wells Fargo & Co
 
976,227
84,336,251
 
 
 
504,410,135
Capital Markets - 0.7%
 
 
 
Blackrock Inc
 
97,264
112,399,251
Charles Schwab Corp/The
 
149,700
16,440,053
Goldman Sachs Group Inc/The
 
147,085
150,894,502
Lincoln International Inc Class A
 
705,422
17,804,851
Morgan Stanley
 
142,427
30,382,528
Robinhood Markets Inc Class A (b)
 
3,035,779
318,179,997
 
 
 
646,101,182
Consumer Finance - 0.0%
 
 
 
American Express Co
 
119,987
39,616,108
Financial Services - 1.9%
 
 
 
Block Inc Class A (b)
 
139,395
11,433,178
Mastercard Inc Class A
 
1,270,425
748,674,157
Paragon Biosciences Emalex Capital Inc Adjustment Escrow (d)(f)
 
2,190,984
109,549
Paragon Biosciences Emalex Capital Inc Indemnity Escrow (f)
 
2,190,984
1,862,336
Paragon Biosciences Emalex Capital Inc Milestone 1 June 10, 2028 (d)(f)
 
2,190,984
1,884,247
Paragon Biosciences Emalex Capital Inc Milestone 2 (d)(f)
 
2,190,984
416,287
Paragon Biosciences Emalex Capital Inc ODT Royalty (d)(f)
 
2,190,984
22
Paragon Biosciences Emalex Capital Inc Ombakay Royalty (d)(f)
 
2,190,984
898,303
Paragon Biosciences Emalex Capital Inc Priority Review Voucher Sale (d)(f)
 
2,190,984
22
Paragon Biosciences Emalex Capital Inc Shareholder Representative Escrow (f)
 
2,190,984
22
Stripe Global Holdings Inc (d)(f)
 
205,500
14,265,810
Toast Inc Class A (b)
 
1,330,811
45,367,347
Visa Inc Class A
 
2,743,914
1,040,958,654
 
 
 
1,865,869,934
TOTAL FINANCIALS
 
 
3,055,997,359
Health Care - 12.5%
 
 
 
Biotechnology - 7.5%
 
 
 
AbbVie Inc
 
502,864
128,944,387
Absci Corp (b)
 
8,022,967
72,527,622
Akouos Inc (b)(f)(g)
 
1,254,446
188,166
Alnylam Pharmaceuticals Inc (b)
 
894,221
215,230,052
Amgen Inc
 
451,584
194,126,930
Antares Therapeutics Inc (b)(d)(f)
 
159,408
234,329
ArriVent Biopharma Inc (b)
 
323,640
9,725,382
Arrowhead Pharmaceuticals Inc (b)
 
2,605,269
214,648,113
Beam Therapeutics Inc (b)(g)
 
3,457,347
101,749,722
BeOne Medicines Ltd ADR (b)
 
624,125
224,422,868
Biogen Inc (b)
 
157,258
34,069,946
Biohaven Ltd (b)
 
160,980
2,458,165
Biomea Fusion Inc (b)(g)
 
2,708,445
4,550,188
Biomea Fusion Inc warrants 12/20/2026 (b)
 
801,300
16,415
Boundless Bio Inc (b)(g)
 
899,159
2,526,637
CAMP4 Therapeutics Corp (d)
 
422,196
1,671,896
CAMP4 Therapeutics Corp (b)
 
399,577
1,582,325
Candel Therapeutics Inc (b)
 
2,291,249
29,946,624
Caris Life Sciences Inc (b)
 
891,492
22,724,131
Cibus Inc Class A (b)
 
3,398,823
5,506,093
Crescent Biopharma Inc (b)(d)
 
646,839
10,737,527
Crescent Biopharma Inc (b)
 
292,318
4,852,479
Cyclerion Therapeutics Inc (b)(e)(g)
 
217,988
802,196
Damora Therapeutics Inc (b)
 
1,835,051
51,711,737
Denali Therapeutics Inc (b)
 
1,452,654
34,515,059
Deverra Therapeutics (b)(d)(f)
 
59,780
0
Dianthus Therapeutics Inc (b)
 
1,592,149
168,146,856
Disc Medicine Inc (b)
 
54,625
4,296,256
Dyne Therapeutics Inc (b)
 
3,157,625
80,298,404
Eikon Therapeutics Inc (b)
 
734,417
7,682,002
Epicrispr Biotechnologies Inc warrants 8/10/2028 (b)(f)
 
7,747,133
76
Foghorn Therapeutics Inc (b)
 
1,834,180
10,528,193
Freenome Inc (d)
 
246,993
3,653,026
Freenome Inc Class A (b)(g)
 
397,340
5,876,659
Generate Biomedicines Inc (g)
 
2,222,692
33,940,507
Hemab Therapeutics Holdings Inc
 
523,853
23,955,798
Ideaya Biosciences Inc (b)
 
4,738,996
190,033,740
Immuneering Corp (b)(g)
 
2,940,043
14,670,815
Immunome Inc (b)
 
4,903,773
134,412,418
Immunovant Inc (b)
 
5,092,337
207,869,196
Insmed Inc (b)
 
611,822
74,532,156
Ionis Pharmaceuticals Inc (b)(e)
 
8,503,655
513,280,616
Jade Biosciences Inc (b)
 
1,191,884
25,458,642
Kailera Therapeutics Inc (b)
 
700,903
10,793,906
Korsana Biosciences (c)(d)(e)(f)
 
3,770,600
16,854,582
Krystal Biotech Inc (b)
 
816,132
293,285,196
Kymera Therapeutics Inc (b)
 
2,247,282
266,999,574
Moderna Inc (b)
 
8,246,175
1,157,268,200
Natera Inc (b)
 
93,459
30,090,060
Nurix Therapeutics Inc (b)
 
645,267
16,634,983
Odyssey Therapeutics Inc (b)(g)
 
1,104,534
27,083,174
Odyssey Therapeutics Inc (h)
 
584,321
14,327,551
ORIC Pharmaceuticals Inc (b)(g)
 
717,487
9,320,156
Oruka Therapeutics Inc (b)(g)
 
1,294,135
119,862,784
Parabilis Medicines Inc (h)
 
1,094,672
42,703,155
Parabilis Medicines Inc (h)(i)
 
1,108,296
41,072,896
Parabilis Medicines Inc (g)
 
478,759
18,676,388
Praxis Precision Medicines Inc (b)
 
107,380
37,615,214
Rallybio Corp (b)
 
207,412
3,482,447
Regeneron Pharmaceuticals Inc
 
142,709
114,035,908
Revolution Medicines Inc (b)
 
2,472,885
508,350,969
Roivant Sciences Ltd (b)
 
23,044,528
798,262,450
Sana Biotechnology Inc (b)
 
10,495,617
40,618,038
Scholar Rock Holding Corp (b)
 
4,533,645
257,511,036
Sigilon Therapeutics Inc rights (b)(f)
 
28,234
250,435
Spyre Therapeutics Inc (b)
 
2,760,132
246,562,592
Summit Therapeutics Inc (b)
 
2,047,862
27,891,880
Tango Therapeutics Inc (b)
 
2,810,958
64,202,281
Taysha Gene Therapies Inc (b)
 
4,170,948
23,732,694
Tectonic Therapeutic Inc (b)(g)
 
754,390
22,586,437
Tubulis GmbH escrow shares (d)(f)
 
7,200
25,128
Tubulis GmbH escrow shares (d)(f)
 
7,200
144
Tubulis GmbH milestone 1 rights (b)(d)(f)
 
7,200
510,624
Tubulis GmbH milestone 10 rights (b)(d)(f)
 
7,200
15,984
Tubulis GmbH milestone 11 rights (b)(d)(f)
 
7,200
15,192
Tubulis GmbH milestone 2 rights (b)(d)(f)
 
7,200
776,016
Tubulis GmbH milestone 3 rights (b)(d)(f)
 
7,200
346,320
Tubulis GmbH milestone 4 rights (b)(d)(f)
 
7,200
401,544
Tubulis GmbH milestone 5 rights (b)(d)(f)
 
7,200
67,464
Tubulis GmbH milestone 6 rights (b)(d)(f)
 
7,200
213,120
Tubulis GmbH milestone 7 rights (b)(d)(f)
 
7,200
206,496
Tubulis GmbH milestone 8 rights (b)(d)(f)
 
7,200
33,696
Tubulis GmbH milestone 9 rights (b)(d)(f)
 
7,200
33,696
Vaxcyte Inc (b)
 
657,121
39,913,530
Vera Therapeutics Inc Class A (b)
 
871,547
29,702,322
Vertex Pharmaceuticals Inc (b)
 
181,041
98,580,445
 
 
 
7,249,021,056
Health Care Equipment & Supplies - 0.6%
 
 
 
Abbott Laboratories
 
4,324
477,197
Blink Health LLC Class A1 (b)(d)(f)
 
250,304
9,423,946
Butterfly Network Inc Class A (b)(g)
 
11,212,206
88,464,305
Ceribell Inc (b)
 
247,539
5,935,985
Dexcom Inc (b)
 
456,564
41,574,718
Glaukos Corp (b)
 
493,100
88,541,036
Globus Medical Inc Class A (b)
 
140,874
11,462,917
Intuitive Surgical Inc (b)
 
469,451
176,917,304
Medical Microinstruments Inc/Italy warrants 2/16/2031 (b)(d)(f)
 
11,774
262,678
Medline Inc Class A
 
1,049,822
36,775,265
Novocure Ltd (b)(e)
 
5,874,496
103,684,854
Procept Biorobotics Corp (b)(g)
 
303,924
6,443,189
Saluda Medical Inc (d)(h)
 
327,633
1,091,735
Saluda Medical Inc depository receipt
 
1,990,051
663,123
Saluda Medical Inc warrants (b)(d)(h)
 
1
0
 
 
 
571,718,252
Health Care Providers & Services - 0.4%
 
 
 
Alignment Healthcare Inc (b)
 
1,453,223
19,473,188
Blue Marlin Therapeutics, Inc. (d)(f)
 
895
55,938
Cardinal Health Inc
 
206,358
48,415,714
Conformal Medical Inc Adjustment Escrow shares (d)(f)
 
1,240,316
12,403
Conformal Medical Inc Shareholder Rep Escrow shares (d)(f)
 
1,240,316
24,806
Conformal Medical Inc Vizara Med Escrow shares (d)(f)
 
1,240,316
12
CVS Health Corp
 
432,983
40,661,434
Guardant Health Inc (b)
 
173,243
27,549,102
Hims & Hers Health Inc Class A (b)(g)
 
476,120
14,083,630
McKesson Corp
 
106,938
94,674,350
Omada Health Inc (b)(g)
 
1,007,298
24,729,166
Quest Diagnostics Inc
 
204,400
49,117,320
Scorpion Therapeutics Inc (b)(d)(f)
 
2,530,180
25
Scorpion Therapeutics Inc rights (b)(d)(f)
 
2,530,180
2,100,050
UnitedHealth Group Inc
 
264,552
103,019,194
 
 
 
423,916,332
Health Care Technology - 0.0%
 
 
 
Allotera Therapeutics Inc warrants 8/22/2035 (b)(d)(f)
 
134,529
240,807
Candid Therapeutics Adjustment Escrow shares (d)(f)
 
3,627,103
36,271
Candid Therapeutics milestone 1 rights (b)(d)(f)
 
3,627,103
253,898
Candid Therapeutics milestone 2 rights (b)(d)(f)
 
3,627,103
145,084
Candid Therapeutics Shareholder Rep Escrow shares (d)(f)
 
3,627,103
36
HeartFlow Inc (b)
 
501,384
25,264,740
Prognomiq Inc (b)(d)(f)
 
183,441
7,337
 
 
 
25,948,173
Life Sciences Tools & Services - 0.4%
 
 
 
10X Genomics Inc Class A (b)
 
200,145
12,499,055
Danaher Corp
 
204,755
43,727,478
Illumina Inc (b)
 
400,700
85,601,541
Repligen Corp (b)
 
127,375
23,052,328
Thermo Fisher Scientific Inc
 
288,744
178,183,922
 
 
 
343,064,324
Pharmaceuticals - 3.6%
 
 
 
Adimab LLC (b)(d)(f)(j)
 
3,162,765
37,288,999
Adimab LLC (b)(d)(f)(j)
 
3,162,765
15,212,900
Amylyx Pharmaceuticals Inc (b)
 
656,484
22,156,335
Atea Pharmaceuticals Inc (b)
 
3,125,767
16,722,853
Avalyn Pharma Inc
 
267,270
9,282,287
Braveheart Bio Inc
 
779,600
19,879,800
Bristol-Myers Squibb Co
 
316,576
21,150,443
Definium Therapeutics Inc (b)
 
562,849
22,356,362
Eli Lilly & Co
 
2,251,837
2,604,767,413
Harmony Biosciences Holdings Inc (b)
 
524,854
20,668,751
Kardigan Inc (h)
 
645,577
13,014,832
Kardigan Inc (b)
 
598,548
12,066,728
LB Pharmaceuticals Inc (d)
 
201,198
8,557,756
LENZ Therapeutics Inc (b)(g)
 
809,716
4,218,620
Lexicon Pharmaceuticals Inc (b)
 
20,695,099
46,563,973
Maze Therapeutics Inc (b)(g)
 
95,120
2,527,338
Nektar Therapeutics (b)(e)(g)
 
1,850,478
132,087,120
Nuvation Bio Inc Class A (b)(e)(g)
 
17,697,414
117,864,777
Ocular Therapeutix Inc (b)
 
9,704,363
101,798,768
Optinose Inc (b)(f)
 
364,134
4
Optinose Inc warrants 11/23/2027 (b)(f)
 
694,735
7
Pfizer Inc
 
79,250
2,255,455
Pfizer Inc rights (b)(f)
 
3,876,351
20,971,059
Rapport Therapeutics Inc (b)
 
2,257,056
109,850,916
Roche Holding AG
 
35,426
15,461,487
Roche Holding AG rights (b)(f)
 
3,405,875
5,721,870
Seaport Therapeutics Inc (b)(g)
 
427,690
10,127,699
Sienna Biopharmaceuticals Inc (b)(f)
 
1,339,097
134
Skyhawk Therapeutics Inc (b)(d)(f)
 
685,377
43,281,558
Skyhawk Therapeutics Inc rights 5/23/2028 (b)(d)(f)
 
481,725
4
Structure Therapeutics Inc ADR (b)
 
230,492
10,581,888
Tarsus Pharmaceuticals Inc (b)
 
228,677
16,976,980
Trevi Therapeutics Inc (b)
 
1,039,015
17,247,649
VeraDermics Inc (g)
 
771,423
75,915,737
Wave Life Sciences Inc
 
1,659,857
8,133,299
 
 
 
3,564,711,801
TOTAL HEALTH CARE
 
 
12,178,379,938
Industrials - 3.2%
 
 
 
Aerospace & Defense - 0.8%
 
 
 
Anduril Industries Inc Class B (b)(d)(f)
 
4,798
352,653
Anduril Industries Inc Class C (b)(d)(f)
 
2
147
Arxis Inc Class A (g)
 
247,694
12,823,118
Beta Technologies Inc Class A (b)
 
3,193,604
64,191,440
Boeing Co (b)
 
837,362
173,987,076
GE Aerospace
 
1,581,433
530,902,873
Lockheed Martin Corp
 
32,959
18,497,580
 
 
 
800,754,887
Air Freight & Logistics - 0.1%
 
 
 
FedEx Corp
 
65,040
21,294,096
United Parcel Service Inc Class B
 
600,069
62,545,192
 
 
 
83,839,288
Building Products - 0.1%
 
 
 
Madison Air Solutions Corp (d)
 
350,588
8,329,971
Madison Air Solutions Corp Class A
 
1,615,403
42,646,639
Trane Technologies PLC
 
17,978
7,989,423
 
 
 
58,966,033
Construction & Engineering - 0.2%
 
 
 
Comfort Systems USA Inc
 
46,941
72,552,948
Fluor Corp (b)
 
394,515
21,505,013
Quanta Services Inc
 
123,763
75,135,280
 
 
 
169,193,241
Electrical Equipment - 0.7%
 
 
 
Bloom Energy Corp Class A (b)
 
371,311
76,601,459
Eaton Corp PLC
 
196,107
78,811,481
Emerson Electric Co
 
119,788
18,260,483
Empower Semiconductor Inc (d)(f)
 
1,061,500
116,765
GE Vernova Inc
 
446,620
401,301,469
Vertiv Holdings Co Class A
 
397,584
102,862,932
 
 
 
677,954,589
Ground Transportation - 0.2%
 
 
 
Avis Budget Group Inc (b)(g)
 
9,989
1,473,278
Fedex Freight Holding Co Inc
 
29,971
4,008,322
Neutron Holdings Inc (d)(h)
 
842,272
34,010,943
Neutron Holdings Inc (b)
 
134,500
5,431,110
Old Dominion Freight Line Inc
 
224,518
44,894,619
Uber Technologies Inc (b)
 
487,219
36,858,117
Union Pacific Corp
 
154,259
46,381,054
 
 
 
173,057,443
Industrial Conglomerates - 0.0%
 
 
 
3M Co
 
159,747
27,449,326
Honeywell International Inc
 
128,667
27,474,265
 
 
 
54,923,591
Machinery - 0.4%
 
 
 
Caterpillar Inc
 
381,433
304,181,375
Deere & Co
 
80,057
52,430,130
Illinois Tool Works Inc
 
131,682
36,261,272
 
 
 
392,872,777
Passenger Airlines - 0.7%
 
 
 
Alaska Air Group Inc (b)
 
465,909
19,256,019
American Airlines Group Inc (b)
 
3,643,703
48,934,931
Delta Air Lines Inc
 
2,414,711
188,347,458
JetBlue Airways Corp (b)
 
10,003
46,014
Southwest Airlines Co
 
3,363,426
129,592,804
United Airlines Holdings Inc (b)
 
2,927,632
316,154,980
Wheels Up Experience Inc Class A rights (b)(f)
 
80,889
1
Wheels Up Experience Inc Stage 1 rights (b)(f)
 
80,889
1
Wheels Up Experience Inc Stage 3 rights (b)(f)
 
80,890
0
 
 
 
702,332,208
TOTAL INDUSTRIALS
 
 
3,113,894,057
Information Technology - 49.5%
 
 
 
Communications Equipment - 2.5%
 
 
 
Arista Networks Inc (b)
 
990,325
193,796,699
Ciena Corp (b)
 
5,251,405
2,010,237,835
Lumentum Holdings Inc (b)
 
254,911
233,182,386
 
 
 
2,437,216,920
Electronic Equipment, Instruments & Components - 0.4%
 
 
 
Coherent Corp (b)
 
166,619
46,291,757
Corning Inc
 
2,585,019
384,469,876
Flex Ltd (b)
 
35,256
3,851,718
 
 
 
434,613,351
IT Services - 1.1%
 
 
 
Akamai Technologies Inc (b)
 
415,786
45,162,675
Cloudflare Inc Class A (b)
 
2,251,851
687,062,259
CoreWeave Inc Class A (b)
 
32,859
2,789,401
Fastly Inc Class A (b)
 
1,881,175
42,871,978
IBM Corporation
 
188,725
44,137,116
Kyndryl Holdings Inc (b)
 
438,424
5,896,803
MongoDB Inc Class A (b)
 
41,038
18,605,398
Okta Inc Class A (b)
 
465,277
80,511,532
Quantinuum Inc Class A (g)
 
15,264
764,726
Snowflake Inc (b)
 
328,673
108,932,092
Twilio Inc Class A (b)
 
30,600
7,210,278
 
 
 
1,043,944,258
Semiconductors & Semiconductor Equipment - 25.0%
 
 
 
Advanced Micro Devices Inc (b)
 
1,507,810
709,756,323
Applied Materials Inc
 
492,600
225,802,914
ARM Holdings PLC ADR (b)
 
78,650
19,026,222
Astera Labs Inc (b)
 
1,476,293
438,429,495
Broadcom Inc
 
6,063,246
2,245,462,524
Cerebras Systems Inc B - 180 Day Lockup Final Release (h)
 
552,594
101,809,919
Cerebras Systems Inc B - Lockup Released
 
986,956
181,836,773
Cerebras Systems Inc B - October 14, 2026 Lockup Release (h)
 
228,748
42,144,532
Cerebras Systems Inc B - October 28, 2026 Lockup Release (h)
 
228,748
42,144,532
Cerebras Systems Inc B - September 16, 2026 Lockup Release (h)
 
172,203
31,726,680
Cerebras Systems Inc B - September 2, 2026 Lockup Release (h)
 
172,203
31,726,680
Cerebras Systems Inc B - September 30, 2026 Lockup Release (h)
 
228,748
42,144,532
Cerebras Systems Inc Class A (b)
 
247,858
45,665,358
Cirrus Logic Inc (b)
 
10,002
1,095,318
Enphase Energy Inc (b)
 
131,937
4,805,146
First Solar Inc (b)
 
207,223
41,838,324
GlobalFoundries Inc
 
396,545
17,721,596
Impinj Inc (b)
 
1,018,526
177,549,452
Intel Corp (b)
 
2,408,363
215,572,572
KLA Corp
 
1,976,553
346,786,224
Lam Research Corp
 
904,193
272,605,148
Marvell Technology Inc
 
2,370,699
501,782,150
Micron Technology Inc
 
1,220,386
1,170,020,670
Monolithic Power Systems Inc
 
73,622
93,335,763
NVIDIA Corp
 
74,361,515
16,417,535,282
ON Semiconductor Corp (b)
 
1,215,037
90,022,091
SiTime Corp (b)
 
932,471
527,237,753
Teradyne Inc
 
524,954
183,644,658
Texas Instruments Inc
 
365,465
95,353,473
 
 
 
24,314,582,104
Software - 9.4%
 
 
 
Adobe Inc (b)
 
160,821
47,086,781
Asapp Inc warrants 8/28/2028 (b)(d)(f)
 
1,007,060
211,482
Atlassian Corp Class A (b)
 
39,304
7,631,658
Autodesk Inc (b)
 
185,493
47,955,505
Canva Inc Class A (b)(d)(f)
 
9,474
14,185,704
Celestial AI Inc (Milestone 1) rights (b)(d)(f)
 
1,325,820
5,435,862
Celestial AI Inc (Milestone 2) rights (b)(d)(f)
 
1,325,820
3,022,870
Celestial AI Inc (Milestone 3) rights (b)(d)(f)
 
1,325,820
649,652
Celestial AI Inc escrow shares (d)(f)
 
1,325,820
13
Circle Internet Group Inc Class A (b)(g)
 
328,665
31,403,941
Crowdstrike Holdings Inc Class A (b)
 
2,306,920
532,898,520
Databricks Inc (d)(f)
 
32,600
8,247,800
Datadog Inc Class A (b)
 
454,249
107,675,183
Elastic NV (b)
 
63,360
6,180,768
Figma Inc Class A (b)
 
524,532
14,419,385
HubSpot Inc (b)
 
81,596
21,325,931
Intuit Inc
 
119,739
43,022,223
Microsoft Corp
 
11,080,646
5,621,100,909
Monday.com Ltd (b)
 
4,989
504,587
Nutanix Inc Class A (b)(e)
 
13,844,092
949,289,388
OpenAI Group Pbc Class A (d)(f)
 
18,000
12,378,420
Oracle Corp
 
4,347,415
648,286,525
Palantir Technologies Inc Class A (b)
 
1,950,946
363,617,315
Palo Alto Networks Inc (b)
 
449,367
171,716,612
Rubrik Inc Class A (b)
 
1,375,230
127,951,399
Salesforce Inc
 
120,277
30,976,139
ServiceNow Inc (b)
 
1,314,055
194,466,999
Workday Inc Class A (b)
 
138,162
27,280,087
Zoom Communications Inc Class A (b)
 
1,610,311
155,684,867
Zscaler Inc (b)
 
29,963
5,644,580
 
 
 
9,200,251,105
Technology Hardware, Storage & Peripherals - 11.1%
 
 
 
Apple Inc
 
22,514,305
7,133,657,539
Everpure Inc Class A (b)(e)
 
17,084,735
1,588,026,118
Sandisk Corp (b)
 
1,182,755
1,853,022,259
Western Digital Corp
 
700,902
315,791,396
 
 
 
10,890,497,312
TOTAL INFORMATION TECHNOLOGY
 
 
48,321,105,050
Materials - 0.4%
 
 
 
Chemicals - 0.1%
 
 
 
Corteva Inc
 
402,630
34,074,577
Dow Inc
 
458,333
13,988,323
Farmers Business Network Inc (b)(d)(f)
 
158,470
71,312
Farmers Business Network Inc warrants 9/27/2033 (b)(d)(f)
 
739,310
524,910
Mosaic Co/The
 
659,208
15,900,097
 
 
 
64,559,219
Construction Materials - 0.0%
 
 
 
James Hardie Industries PLC (b)
 
435,294
12,932,584
Containers & Packaging - 0.0%
 
 
 
Avery Dennison Corp
 
172,700
30,068,797
Smurfit Westrock PLC
 
46,343
2,173,487
 
 
 
32,242,284
Metals & Mining - 0.3%
 
 
 
Freeport-McMoRan Inc
 
3,980,839
301,508,746
Nucor Corp
 
80,559
20,110,749
 
 
 
321,619,495
TOTAL MATERIALS
 
 
431,353,582
Real Estate - 0.1%
 
 
 
Health Care REITs - 0.0%
 
 
 
Welltower Inc
 
203,062
47,971,367
Real Estate Management & Development - 0.0%
 
 
 
CBRE Group Inc Class A (b)
 
230,917
33,670,007
Specialized REITs - 0.1%
 
 
 
American Tower Corp
 
217,746
38,257,973
Equinix Inc
 
14,127
14,787,013
 
 
 
53,044,986
TOTAL REAL ESTATE
 
 
134,686,360
TOTAL UNITED STATES
 
 
92,968,108,669
 
TOTAL COMMON STOCKS
 (Cost $32,227,226,255)
 
 
 
95,575,165,667
 
 
 
 
Convertible Corporate Bonds - 0.0%
 
 
Principal
Amount (a)
 
Value ($)
 
UNITED STATES - 0.0%
 
 
 
Consumer Staples - 0.0%
 
 
 
Tobacco - 0.0%
 
 
 
JUUL Labs Inc 5% 9/28/2029 (d)(f)(l)
 
20,996,474
21,116,155
Financials - 0.0%
 
 
 
Financial Services - 0.0%
 
 
 
Tenstorrent Holdings Inc 15% 12/31/2026 (d)(f)
 
5,437,296
6,361,636
Health Care - 0.0%
 
 
 
Health Care Equipment & Supplies - 0.0%
 
 
 
Kardium Inc/US 10% 12/31/2026 (d)(f)
 
2,312,948
1,905,869
Health Care Technology - 0.0%
 
 
 
Allotera Therapeutics Inc 0% 12/31/2199 (d)(f)(k)
 
2,085,443
2,295,239
Pharmaceuticals - 0.0%
 
 
 
Galvanize Therapeutics 10% 2/28/2027 (d)(f)
 
851,399
1,112,522
TOTAL HEALTH CARE
 
 
5,313,630
Information Technology - 0.0%
 
 
 
Software - 0.0%
 
 
 
Evozyne Inc 6% 9/13/2028 pay-in-kind (d)(f)
 
4,547,314
5,409,940
Materials - 0.0%
 
 
 
Chemicals - 0.0%
 
 
 
Farmers Business Network Inc 15% 12/31/2199 (d)(f)
 
977,737
535,995
TOTAL UNITED STATES
 
 
38,737,356
 
TOTAL CONVERTIBLE CORPORATE BONDS
 (Cost $37,729,369)
 
 
 
38,737,356
 
 
 
 
Convertible Preferred Stocks - 2.0%
 
 
Shares
Value ($)
 
CANADA - 0.0%
 
 
 
Health Care - 0.0%
 
 
 
Biotechnology - 0.0%
 
 
 
Deep Genomics Inc Series C (b)(d)(f)
 
682,293
7,846,370
Information Technology - 0.0%
 
 
 
Software - 0.0%
 
 
 
Taalas Inc Series B (b)(d)(f)
 
95,900
14,625,709
TOTAL CANADA
 
 
22,472,079
CHINA - 0.1%
 
 
 
Communication Services - 0.1%
 
 
 
Interactive Media & Services - 0.1%
 
 
 
Bytedance Ltd Series E1 (b)(d)(f)
 
403,450
133,328,122
ESTONIA - 0.0%
 
 
 
Information Technology - 0.0%
 
 
 
Software - 0.0%
 
 
 
Bolt Technology OU Series E (b)(d)(f)
 
72,621
16,290,236
FRANCE - 0.0%
 
 
 
Health Care - 0.0%
 
 
 
Health Care Technology - 0.0%
 
 
 
DNA Script SAS Series B (b)(d)(f)
 
22
177
DNA Script SAS Series C (b)(d)(f)
 
10,882
1,299,517
 
 
 
 
TOTAL FRANCE
 
 
1,299,694
INDIA - 0.0%
 
 
 
Consumer Discretionary - 0.0%
 
 
 
Specialty Retail - 0.0%
 
 
 
Valuedrive Technologies Pvt Ltd Series A (d)(f)
 
363
514,782
Valuedrive Technologies Pvt Ltd Series B (d)(f)
 
729
1,033,818
Valuedrive Technologies Pvt Ltd Series C (d)(f)
 
3
4,254
Valuedrive Technologies Pvt Ltd Series C1 (d)(f)
 
2
2,836
Valuedrive Technologies Pvt Ltd Series G (d)(f)
 
4,671,150
1,840,139
Valuedrive Technologies Pvt Ltd Series S2 (d)(f)
 
177
251,009
 
 
 
 
TOTAL INDIA
 
 
3,646,838
ISRAEL - 0.1%
 
 
 
Health Care - 0.0%
 
 
 
Health Care Equipment & Supplies - 0.0%
 
 
 
InSightec Ltd Series G (b)(d)(f)
 
6,623,267
4,901,218
Industrials - 0.0%
 
 
 
Electrical Equipment - 0.0%
 
 
 
Element Labs Inc Series A (b)(d)(f)
 
530,700
12,460,836
Element Labs Inc Series B (b)(d)(f)
 
286,800
6,920,484
Element Labs Inc Series C (d)(f)
 
259,200
7,164,288
TOTAL INDUSTRIALS
 
 
26,545,608
Information Technology - 0.1%
 
 
 
Semiconductors & Semiconductor Equipment - 0.1%
 
 
 
Xsight Labs Ltd Series D (b)(d)(f)
 
787,863
10,163,433
Xsight Labs Ltd Series F (b)(d)(f)
 
1,303,469
13,634,286
Xsight Labs Ltd Series G (d)(f)
 
250,600
4,210,079
TOTAL INFORMATION TECHNOLOGY
 
 
28,007,798
TOTAL ISRAEL
 
 
59,454,624
UNITED KINGDOM - 0.0%
 
 
 
Health Care - 0.0%
 
 
 
Biotechnology - 0.0%
 
 
 
Quell Therapeutics Ltd Series B (b)(d)(f)
 
3,870,630
9,599,162
Information Technology - 0.0%
 
 
 
Software - 0.0%
 
 
 
Nscale Limited Series B (d)(f)
 
1,062,000
23,417,100
TOTAL UNITED KINGDOM
 
 
33,016,262
UNITED STATES - 1.8%
 
 
 
Consumer Discretionary - 0.0%
 
 
 
Automobiles - 0.0%
 
 
 
Rad Power Bikes Inc Series A (b)(d)(f)
 
154,174
1
Rad Power Bikes Inc Series C (b)(d)(f)
 
606,658
6
Rad Power Bikes Inc Series D (b)(d)(f)
 
1,071,300
11
Waymo LLC Series A2 (b)(d)(f)
 
44,767
7,553,537
Waymo LLC Series C2 (b)(d)(f)
 
33,554
5,513,593
 
 
 
13,067,148
Hotels, Restaurants & Leisure - 0.0%
 
 
 
Discord Inc Series I (b)(d)(f)
 
70,000
1,645,699
Textiles, Apparel & Luxury Goods - 0.0%
 
 
 
Sail Biomedicines Series B (b)(d)(f)
 
344,496
6,228,488
TOTAL CONSUMER DISCRETIONARY
 
 
20,941,335
Consumer Staples - 0.0%
 
 
 
Consumer Staples Distribution & Retail - 0.0%
 
 
 
GoBrands Inc Series G (b)(d)(f)
 
125,688
7,250,941
GoBrands Inc Series H (b)(d)(f)
 
104,311
7,672,074
 
 
 
14,923,015
Food Products - 0.0%
 
 
 
AgBiome LLC Series C (b)(d)(f)
 
1,060,308
10
AgBiome LLC Series D (b)(d)(f)
 
852,431
8,524
 
 
 
8,534
Tobacco - 0.0%
 
 
 
JUUL Labs Inc Series E (b)(d)(f)
 
22,033
45,829
TOTAL CONSUMER STAPLES
 
 
14,977,378
Financials - 0.0%
 
 
 
Financial Services - 0.0%
 
 
 
Akeana Series C (b)(d)(f)
 
372,100
4,048,448
Stripe Global Holdings Inc Series H (d)(f)
 
88,200
6,122,844
Tenstorrent Holdings Inc Series C1 (b)(d)(f)
 
178,216
15,143,014
Tenstorrent Holdings Inc Series D1 (b)(d)(f)
 
179,036
15,910,929
Tenstorrent Holdings Inc Series D2 (b)(d)(f)
 
47,252
4,083,990
TOTAL FINANCIALS
 
 
45,309,225
Health Care - 0.5%
 
 
 
Biotechnology - 0.2%
 
 
 
Altos Labs Inc Series B (b)(d)(f)
 
485,428
12,145,409
Altos Labs Inc Series C (b)(d)(f)
 
108,056
2,703,561
Ankyra Therapeutics Series B (b)(d)(f)
 
1,356,730
7,475,582
Asimov Inc Series B (b)(d)(f)
 
82,174
2,176,789
Bright Peak Therapeutics Inc. Series B (b)(d)(f)
 
1,272,915
1,476,581
Bright Peak Therapeutics Inc. Series C (b)(d)(f)
 
2,299,209
2,046,296
Cardurion Pharmaceuticals Inc Series B (b)(d)(f)
 
1,181,602
7,006,900
Castle Creek Biosciences Inc Series B (b)(d)(f)
 
16,803
2,415,599
Castle Creek Biosciences Inc Series C (b)(d)(f)
 
13,100
2,338,743
Castle Creek Biosciences Inc Series D1 (b)(d)(f)
 
19,720
3,335,639
Castle Creek Biosciences Inc Series D2 (b)(d)(f)
 
6,341
930,795
CELLANOME Inc Series B (b)(d)(f)
 
1,040,007
8,382,456
City Therapeutics Inc Series A (b)(d)(f)
 
800,961
10,380,455
City Therapeutics Inc Series B (d)(f)
 
104,700
1,529,667
Cleerly Inc Series C (b)(d)(f)
 
983,054
12,553,600
Element Biosciences Inc Series B (b)(d)(f)
 
1,096,312
8,715,680
Element Biosciences Inc Series C (b)(d)(f)
 
480,109
5,818,921
Element Biosciences Inc Series D (b)(d)(f)
 
224,866
1,866,388
Element Biosciences Inc Series D1 (b)(d)(f)
 
224,866
1,866,388
ElevateBio LLC Series C (b)(d)(f)
 
1,534,100
2,822,744
Epicrispr Biotechnologies Inc Series C (d)(f)
 
11,620,700
880,595
Genesis Therapeutics Inc Series D (b)(d)(f)
 
1,654,854
12,907,861
LifeMine Therapeutics Inc Series C (b)(d)(f)
 
7,794,524
11,457,950
National Resilience LLC Series B (b)(d)(f)
 
1,277,345
5,658,638
National Resilience LLC Series C (b)(d)(f)
 
379,000
3,013,050
Serif Biomedicines, Inc (d)(f)
 
3,296,106
7,778,810
Sonoma Biotherapeutics Inc Series B (b)(d)(f)
 
2,497,760
3,921,484
Sonoma Biotherapeutics Inc Series B1 (b)(d)(f)
 
1,332,116
2,451,093
Souffle Therapeutics Inc Series B (d)(f)
 
2,507,100
6,769,170
T-Knife Therapeutics Inc Series B (b)(d)(f)
 
995,165
686,663
Treeline Biosciences Series A (b)(d)(f)
 
1,347,260
9,781,108
Treeline Biosciences Series A1 (b)(d)(f)
 
464,216
3,370,208
Triveni Bio Inc Series B (b)(d)(f)
 
4,766,021
5,814,546
Triveni Bio Inc Series C (d)(f)
 
1,588,268
1,985,335
 
 
 
174,464,704
Health Care Equipment & Supplies - 0.1%
 
 
 
Blink Health LLC Series C (b)(d)(f)
 
927,374
34,915,631
Blink Health LLC Series D (b)(d)(f)
 
241,612
9,096,692
Kardium Inc/US Series D-6 (b)(d)(f)
 
5,899,008
5,250,117
Kardium Inc/US Series D-6 (Issued June 2025) (b)(d)(f)
 
8,237,435
5,683,830
Kardium Inc/US Series D-7 (Aug 25 Closing) (b)(d)(f)
 
8,754,573
3,501,829
Kardium Inc/US Series D-7 (June 25 1st Closing) (b)(d)(f)
 
398,649
159,460
Kardium Inc/US Series D-7 (June 25 2nd Closing) (b)(d)(f)
 
1,916,096
766,438
Medical Microinstruments Inc/Italy Series C (b)(d)(f)
 
212,985
6,104,150
 
 
 
65,478,147
Health Care Technology - 0.2%
 
 
 
Aledade Inc Series B1 (b)(d)(f)
 
101,470
3,935,007
Aledade Inc Series E1 (b)(d)(f)
 
66,006
2,559,712
Allotera Therapeutics Inc Series B (b)(d)(f)
 
493,529
814,323
Allotera Therapeutics Inc Series C (b)(d)(f)
 
2,090,300
3,762,540
Oura Inc Series D (d)(f)
 
864,427
62,437,562
Oura Inc Series E (d)(f)
 
1,920,845
138,742,635
 
 
 
212,251,779
Pharmaceuticals - 0.0%
 
 
 
Galvanize Therapeutics Series B (b)(d)(f)
 
4,342,265
3,126,431
Galvanize Therapeutics Series C-1 (b)(d)(f)
 
6,788,184
3,054,683
Mentari Therapeutics Inc Series A (d)(f)
 
2,005,263
5,514,473
Mirador Therapeutics Inc Series A (b)(d)(f)
 
2,678,245
10,070,201
Mirador Therapeutics Inc Series B (b)(d)(f)
 
2,942,219
11,121,588
 
 
 
32,887,376
TOTAL HEALTH CARE
 
 
485,082,006
Industrials - 0.1%
 
 
 
Aerospace & Defense - 0.0%
 
 
 
Anduril Industries Inc Series F (b)(d)(f)
 
287,246
21,112,581
Anduril Industries Inc Series G (b)(d)(f)
 
45,100
3,314,850
 
 
 
24,427,431
Air Freight & Logistics - 0.1%
 
 
 
Zipline International Inc Series G (b)(d)(f)
 
180,063
12,984,343
Zipline International Inc Series H (d)(f)
 
307,800
22,195,458
 
 
 
35,179,801
Machinery - 0.0%
 
 
 
Harbinger Motors Inc Series D-1 (d)(f)
 
3,992,056
10,499,107
TOTAL INDUSTRIALS
 
 
70,106,339
Information Technology - 1.1%
 
 
 
Electronic Equipment, Instruments & Components - 0.2%
 
 
 
Menlo Microsystems Inc Series C (b)(d)(f)
 
4,423,488
2,432,918
Menlo Microsystems Inc Series C-1 (d)(f)
 
113,900
125,290
Vast Data Ltd Series A (b)(d)(f)
 
318,221
20,172,029
Vast Data Ltd Series A1 (b)(d)(f)
 
783,248
49,650,091
Vast Data Ltd Series A2 (b)(d)(f)
 
900,985
57,113,440
Vast Data Ltd Series B (b)(d)(f)
 
716,925
45,445,876
Vast Data Ltd Series C (b)(d)(f)
 
20,899
1,324,788
Vast Data Ltd Series E (b)(d)(f)
 
685,070
43,426,587
 
 
 
219,691,019
Semiconductors & Semiconductor Equipment - 0.1%
 
 
 
Alif Semiconductor Series C (b)(d)(f)
 
190,608
6,097,550
Alif Semiconductor Series D (b)(d)(f)
 
251,500
8,440,340
Danger Devices Inc Series B (b)(d)(f)
 
3,437,900
3,094,110
Retym Inc Series C (b)(d)(f)
 
666,292
8,108,774
Retym Inc Series D (b)(d)(f)
 
165,291
2,100,848
SiMa Technologies Inc Series B (b)(d)(f)
 
1,596,216
12,657,993
SiMa Technologies Inc Series B1 (b)(d)(f)
 
106,922
907,768
SiMa Technologies Inc Series C (d)(f)
 
1,115,086
10,236,489
 
 
 
51,643,872
Software - 0.7%
 
 
 
Anthropic PBC Series D-1 (b)(d)(f)
 
235,150
193,370,901
Anthropic PBC Series E (b)(d)(f)
 
45,100
35,066,603
Anthropic PBC Series F (b)(d)(f)
 
66,600
51,783,498
Anthropic PBC Series H (d)(f)
 
9,700
7,542,041
Asapp Inc Series D (b)(d)(f)
 
1,755,238
1,527,057
Canva Inc Series A (b)(d)(f)
 
3,369
5,044,505
Canva Inc Series A2 (b)(d)(f)
 
611
914,868
Crusoe Energy Systems LLC Series D (b)(d)(f)
 
259,289
53,405,755
Crusoe Energy Systems LLC Series E (d)(f)
 
22,214
4,575,418
Crusoe Energy Systems LLC Series F (d)
 
16,991
3,499,571
Databricks Inc Series G (b)(d)(f)
 
250,296
63,324,888
Databricks Inc Series H (b)(d)(f)
 
273,171
69,112,263
Databricks Inc Series J (b)(d)(f)
 
130,663
33,057,739
Databricks Inc Series K (d)(f)
 
8,900
2,251,700
Databricks Inc Series L (d)(f)
 
23,700
5,996,100
Dataminr Inc Series D, 8% (b)(d)(f)
 
1,773,901
11,636,791
Density AI Inc (d)(f)
 
2,475,400
50,003,080
Evozyne Inc Series A (b)(d)(f)
 
444,700
7,226,375
Evozyne Inc Series B (b)(d)(f)
 
247,942
4,138,152
Lyte AI Inc Series B (b)(d)(f)
 
673,357
20,725,928
Lyte AI Inc Series C (d)(f)
 
61,000
2,246,020
OpenAI Group Pbc Series A-3 (d)(f)
 
22,979
15,802,429
Physical Intelligence Inc Series B (d)(f)
 
41,700
19,315,440
Physical Intelligence Inc Series C (d)(f)
 
4,383
2,200,967
Skyryse Inc Series B (b)(d)(f)
 
568,445
13,165,186
Skyryse Inc Series C (d)(f)
 
296,604
7,118,496
Skyryse Inc Series C-1 (d)(f)
 
53,976
1,253,323
 
 
 
685,305,094
Technology Hardware, Storage & Peripherals - 0.1%
 
 
 
Lightmatter Inc Series C1 (b)(d)(f)
 
407,933
24,231,220
Lightmatter Inc Series C2 (b)(d)(f)
 
64,075
3,900,245
Lightmatter Inc Series D (b)(d)(f)
 
426,443
32,081,307
 
 
 
60,212,772
TOTAL INFORMATION TECHNOLOGY
 
 
1,016,852,757
Materials - 0.1%
 
 
 
Chemicals - 0.0%
 
 
 
Farmers Business Network Inc Series G (b)(d)(f)
 
28,363
12,763
Manus Bio Inc Series One-5 (b)(d)(f)
 
736,380
2,768,789
Manus Bio Inc Series One-6 (b)(d)(f)
 
914,609
3,438,930
 
 
 
6,220,482
Metals & Mining - 0.1%
 
 
 
Diamond Foundry Inc Series C (b)(d)(f)
 
1,704,625
57,974,296
TOTAL MATERIALS
 
 
64,194,778
Utilities - 0.0%
 
 
 
Independent Power and Renewable Electricity Producers - 0.0%
 
 
 
Redwood Materials Series C (b)(d)(f)
 
80,057
3,461,665
Redwood Materials Series D (b)(d)(f)
 
18,751
810,793
Redwood Materials Series E (d)(f)
 
5,091
220,135
TOTAL UTILITIES
 
 
4,492,593
TOTAL UNITED STATES
 
 
1,721,956,411
 
TOTAL CONVERTIBLE PREFERRED STOCKS
 (Cost $1,191,720,508)
 
 
 
1,991,464,266
 
 
 
 
Non-Convertible Preferred Stocks - 0.0%
 
 
Shares
Value ($)
 
UNITED STATES - 0.0%
 
 
 
Health Care - 0.0%
 
 
 
Biotechnology - 0.0%
 
 
 
Castle Creek Biosciences Inc Series A4 (b)(d)(f)
  (Cost $15,508,325)
 
46,864
6,862,296
 
 
 
 
Preferred Securities - 0.0%
 
 
Principal
Amount (a)
 
Value ($)
 
CANADA - 0.0%
 
 
 
Information Technology - 0.0%
 
 
 
Software - 0.0%
 
 
 
Taalas Inc 0% (d)(f)(m)
 
8,759,878
9,007,783
UNITED STATES - 0.0%
 
 
 
Consumer Discretionary - 0.0%
 
 
 
Automobiles - 0.0%
 
 
 
Rad Power Bikes Inc 8% 12/31/2199 (d)(f)
 
985,838
318,064
Health Care - 0.0%
 
 
 
Biotechnology - 0.0%
 
 
 
Bright Peak Therapeutics Inc. 8% 2/28/2027 (d)(f)
 
266,833
273,898
TOTAL UNITED STATES
 
 
591,962
 
TOTAL PREFERRED SECURITIES
 (Cost $10,012,549)
 
 
 
9,599,745
 
 
 
 
Money Market Funds - 0.7%
 
 
Yield (%)
Shares
Value ($)
 
Fidelity Cash Central Fund (n)
 
3.69
167,650,337
167,683,867
Fidelity Securities Lending Cash Central Fund (n)(o)
 
3.72
543,303,516
543,357,846
 
TOTAL MONEY MARKET FUNDS
 (Cost $711,033,022)
 
 
 
711,041,713
 
 
 
 
 
 
TOTAL INVESTMENT IN SECURITIES - 100.6%
 (Cost $34,193,230,028)
 
 
 
98,332,871,043
NET OTHER ASSETS (LIABILITIES) - (0.6)%  
(593,182,438)
NET ASSETS - 100.0%
97,739,688,605
 
 
 
Legend
 
(a)
Amount is stated in United States dollars unless otherwise noted.
 
(b)
Non-income producing.
 
(c)
Security or a portion of the security purchased on a delayed delivery or when-issued basis.
 
(d)
Restricted securities (including private placements) - Investment in securities not registered under the Securities Act of 1933 (excluding 144A issues).  At the end of the period, the value of restricted securities (excluding 144A issues) amounted to $2,547,726,444 or 2.6% of net assets.
 
(e)
Affiliated company.
 
(f)
Level 3 security.
 
(g)
Security or a portion of the security is on loan at period end.
 
(h)
Security is subject to lock-up or market standoff agreement. Fair value is based on the unadjusted market price of the equivalent equity security. At the end of the period, the total value of unadjusted equity securities subject to contractual sale restrictions is $2,638,231,799 with varying restriction expiration dates. Under normal market conditions, there are no circumstances that could cause the restrictions to lapse.
 
(i)
Security exempt from registration under Rule 144A of the Securities Act of 1933.  These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers. At the end of the period, the value of these securities amounted to $53,693,865 or 0.1% of net assets.
 
(j)
Investment is owned by a wholly-owned subsidiary (Subsidiary) that is treated as a corporation for U.S. tax purposes.
 
(k)
Coupon rates for floating and adjustable rate securities reflect the rates in effect at period end.
 
(l)
Security initially issued at one coupon which converts to a higher coupon at a specified date. The rate shown is the rate at period end.
 
(m)
Security is perpetual in nature with no stated maturity date.
 
(n)
Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.
 
(o)
Investment made with cash collateral received from securities on loan.
 
At period end, the value of non-cash collateral for securities on loan amounted to $189,707,730.
Additional information on each restricted holding is as follows:
Security
Acquisition Date
Acquisition Cost ($)
 
Adimab LLC
9/17/2014 - 6/5/2015
36,220,587
 
 
 
Adimab LLC
9/17/2014 - 6/5/2015
12,138,388
 
 
 
AgBiome LLC Series C
6/29/2018
6,715,673
 
 
 
AgBiome LLC Series D
9/3/2021
4,751,176
 
 
 
Akeana Series C
1/23/2024
4,748,294
 
 
 
Aledade Inc Series B1
5/7/2021
3,885,358
 
 
 
Aledade Inc Series E1
5/20/2022
3,288,049
 
 
 
Alif Semiconductor Series C
3/8/2022
3,869,064
 
 
 
Alif Semiconductor Series D
4/11/2025
6,794,801
 
 
 
Allotera Therapeutics Inc 0% 12/31/2199
6/14/2024
2,085,443
 
 
 
Allotera Therapeutics Inc Series B
7/9/2021
3,827,268
 
 
 
Allotera Therapeutics Inc Series C
8/22/2025 - 2/17/2026
3,705,872
 
 
 
Allotera Therapeutics Inc warrants 8/22/2035
8/22/2025
0
 
 
 
Altos Labs Inc Series B
7/22/2022
9,295,170
 
 
 
Altos Labs Inc Series C
3/15/2024
2,703,820
 
 
 
Anduril Industries Inc Class B
6/16/2025
196,156
 
 
 
Anduril Industries Inc Class C
6/16/2025
81
 
 
 
Anduril Industries Inc Series F
8/7/2024
6,243,752
 
 
 
Anduril Industries Inc Series G
4/17/2025
1,843,814
 
 
 
Ankyra Therapeutics Series B
8/26/2021
7,640,832
 
 
 
Ant International Co Ltd Class C
5/16/2018
6,690,161
 
 
 
Antares Therapeutics Inc
3/5/2025
455,432
 
 
 
Anthropic PBC Series D-1
5/31/2024
7,055,558
 
 
 
Anthropic PBC Series E
2/14/2025
2,529,501
 
 
 
Anthropic PBC Series F
8/18/2025
9,388,443
 
 
 
Anthropic PBC Series H
5/28/2026
5,713,392
 
 
 
Asapp Inc Series D
8/29/2023
6,777,852
 
 
 
Asapp Inc warrants 8/28/2028
8/29/2023
1
 
 
 
Asimov Inc Series B
10/29/2021
7,615,944
 
 
 
Bending Spoons SpA
10/9/2025
4,870,281
 
 
 
Blink Health LLC Class A1
12/30/2020 - 6/17/2024
7,280,990
 
 
 
Blink Health LLC Series C
11/7/2019 - 7/14/2021
35,403,430
 
 
 
Blink Health LLC Series D
6/17/2024 - 6/25/2024
10,147,704
 
 
 
Blue Marlin Therapeutics, Inc.
10/23/2025
103,869
 
 
 
Bolt Technology OU Series E
1/3/2022
18,866,682
 
 
 
Bright Peak Therapeutics Inc. 8% 2/28/2027
6/2/2026
266,833
 
 
 
Bright Peak Therapeutics Inc. Series B
5/14/2021
4,972,006
 
 
 
Bright Peak Therapeutics Inc. Series C
5/7/2024
2,606,153
 
 
 
Bytedance Ltd Series E1
11/18/2020
44,207,703
 
 
 
CAMP4 Therapeutics Corp
9/9/2025
645,960
 
 
 
Candid Therapeutics Adjustment Escrow shares
6/17/2026
36,271
 
 
 
Candid Therapeutics milestone 1 rights
6/17/2026
253,898
 
 
 
Candid Therapeutics milestone 2 rights
6/17/2026
145,084
 
 
 
Candid Therapeutics Shareholder Rep Escrow shares
6/17/2026
36
 
 
 
Canva Inc Class A
3/18/2024 - 11/12/2025
12,944,994
 
 
 
Canva Inc Series A
9/22/2023
3,593,581
 
 
 
Canva Inc Series A2
9/22/2023
651,730
 
 
 
Cardurion Pharmaceuticals Inc Series B
7/10/2024
5,787,014
 
 
 
Castle Creek Biosciences Inc Series A4
9/29/2016
15,508,325
 
 
 
Castle Creek Biosciences Inc Series B
10/9/2018
6,920,316
 
 
 
Castle Creek Biosciences Inc Series C
12/9/2019
5,395,235
 
 
 
Castle Creek Biosciences Inc Series D1
4/19/2022
4,240,392
 
 
 
Castle Creek Biosciences Inc Series D2
6/28/2021
1,087,099
 
 
 
Celestial AI Inc (Milestone 1) rights
2/25/2025
2,759,160
 
 
 
Celestial AI Inc (Milestone 2) rights
2/25/2025
2,120,090
 
 
 
Celestial AI Inc (Milestone 3) rights
2/25/2025
618,782
 
 
 
Celestial AI Inc escrow shares
2/25/2025
0
 
 
 
CELLANOME Inc Series B
1/8/2024
7,789,652
 
 
 
City Therapeutics Inc Series A
4/17/2024
8,033,238
 
 
 
City Therapeutics Inc Series B
5/20/2026
1,531,709
 
 
 
Cleerly Inc Series C
7/8/2022
11,580,966
 
 
 
Conformal Medical Inc Adjustment Escrow shares
2/18/2026
12,403
 
 
 
Conformal Medical Inc Shareholder Rep Escrow shares
2/18/2026
24,806
 
 
 
Conformal Medical Inc Vizara Med Escrow shares
2/18/2026
12
 
 
 
Crescent Biopharma Inc
10/28/2024 - 12/4/2025
8,636,837
 
 
 
Crusoe Energy Systems LLC Series D
12/10/2024
7,563,938
 
 
 
Crusoe Energy Systems LLC Series E
10/8/2025
1,866,159
 
 
 
Crusoe Energy Systems LLC Series F
8/31/2026
3,499,571
 
 
 
Danger Devices Inc Series B
3/5/2025
3,095,828
 
 
 
Databricks Inc
8/12/2026
8,247,800
 
 
 
Databricks Inc Series G
2/1/2021
14,798,159
 
 
 
Databricks Inc Series H
8/31/2021
20,073,734
 
 
 
Databricks Inc Series J
12/17/2024
12,086,328
 
 
 
Databricks Inc Series K
9/8/2025
1,334,999
 
 
 
Databricks Inc Series L
12/18/2025
4,503,000
 
 
 
Dataminr Inc Series D, 8%
2/18/2015 - 3/6/2015
22,617,238
 
 
 
Deep Genomics Inc Series C
7/21/2021
9,894,067
 
 
 
Density AI Inc
12/5/2025
3,688,309
 
 
 
Deverra Therapeutics
5/1/2018
0
 
 
 
Diamond Foundry Inc Series C
3/15/2021
40,911,000
 
 
 
Discord Inc Series I
9/15/2021
3,854,371
 
 
 
DNA Script SAS
12/17/2021
370,744
 
 
 
DNA Script SAS seed shares
12/17/2021
1,416,515
 
 
 
DNA Script SAS Series B
12/17/2021
17,616
 
 
 
DNA Script SAS Series C
10/1/2021
9,465,708
 
 
 
Element Biosciences Inc Series B
12/13/2019
5,745,333
 
 
 
Element Biosciences Inc Series C
6/21/2021
9,869,457
 
 
 
Element Biosciences Inc Series D
6/28/2024
1,763,691
 
 
 
Element Biosciences Inc Series D1
6/28/2024
1,763,691
 
 
 
Element Labs Inc Series A
2/11/2025
1,957,539
 
 
 
Element Labs Inc Series B
6/27/2025
2,517,789
 
 
 
Element Labs Inc Series C
4/16/2026
7,190,778
 
 
 
ElevateBio LLC Series C
3/9/2021
6,435,550
 
 
 
Empower Semiconductor Inc
7/7/2026
116,765
 
 
 
Epic Games Inc
7/13/2020 - 7/30/2020
29,785,000
 
 
 
Epicrispr Biotechnologies Inc Series C
8/10/2026
880,593
 
 
 
Evozyne Inc 6% 9/13/2028 pay-in-kind
9/14/2023 - 6/30/2026
4,547,314
 
 
 
Evozyne Inc Series A
4/9/2021
9,992,409
 
 
 
Evozyne Inc Series B
9/14/2023
3,840,622
 
 
 
Fanatics Inc Class A
8/13/2020 - 10/24/2022
21,635,851
 
 
 
Farmers Business Network Inc
9/15/2021
9,850,147
 
 
 
Farmers Business Network Inc 15% 12/31/2199
9/29/2023 - 9/25/2025
977,737
 
 
 
Farmers Business Network Inc Series G
9/15/2021
1,762,981
 
 
 
Farmers Business Network Inc warrants 9/27/2033
9/29/2023
0
 
 
 
Freenome Inc
12/5/2025
2,469,930
 
 
 
Galvanize Therapeutics 10% 2/28/2027
7/7/2025
1,087,832
 
 
 
Galvanize Therapeutics Series B
3/29/2022
7,517,698
 
 
 
Galvanize Therapeutics Series C-1
7/7/2025
2,857,908
 
 
 
Genesis Therapeutics Inc Series D
8/10/2023
8,452,332
 
 
 
GoBrands Inc Series G
3/2/2021
31,386,468
 
 
 
GoBrands Inc Series H
7/22/2021
40,523,841
 
 
 
Harbinger Motors Inc Series D-1
8/27/2026
10,499,107
 
 
 
InMed Pharmaceuticals Inc
5/19/2026 - 7/22/2026
15,616,619
 
 
 
InSightec Ltd Series G
6/17/2024
5,880,136
 
 
 
JUUL Labs Inc 5% 9/28/2029
8/25/2026
20,996,474
 
 
 
JUUL Labs Inc Class A
7/6/2018 - 11/4/2025
16,300,063
 
 
 
JUUL Labs Inc Series E
7/6/2018
649,610
 
 
 
Kardium Inc/US 10% 12/31/2026
5/31/2024 - 6/30/2026
2,597,273
 
 
 
Kardium Inc/US Series D-6
12/30/2020
5,992,448
 
 
 
Kardium Inc/US Series D-6 (Issued June 2025)
12/30/2020
8,367,917
 
 
 
Kardium Inc/US Series D-7 (Aug 25 Closing)
5/31/2024 - 6/30/2025
3,943,195
 
 
 
Kardium Inc/US Series D-7 (June 25 1st Closing)
8/6/2024
62,017
 
 
 
Kardium Inc/US Series D-7 (June 25 2nd Closing)
8/6/2024
930,130
 
 
 
Kartos Therapeutics Inc 250M Milestone rights
8/20/2026
0
 
 
 
Kartos Therapeutics Inc 950M Milestone rights
8/20/2026
5,455,500
 
 
 
Korsana Biosciences
4/1/2026
8,916,715
 
 
 
LB Pharmaceuticals Inc
7/29/2026
7,029,858
 
 
 
LifeMine Therapeutics Inc Series C
2/15/2022
15,874,250
 
 
 
Lightmatter Inc Series C1
5/19/2023
6,713,272
 
 
 
Lightmatter Inc Series C2
12/18/2023
1,666,065
 
 
 
Lightmatter Inc Series D
10/11/2024
34,213,735
 
 
 
Lyte AI Inc Series B
8/13/2024
8,542,274
 
 
 
Lyte AI Inc Series C
6/24/2026
2,247,173
 
 
 
Madison Air Solutions Corp
8/24/2026
8,754,182
 
 
 
Manus Bio Inc Series One-5
11/13/2020
7,724,091
 
 
 
Manus Bio Inc Series One-6
3/30/2021
9,593,583
 
 
 
Medical Microinstruments Inc/Italy Series C
2/16/2024
7,099,578
 
 
 
Medical Microinstruments Inc/Italy warrants 2/16/2031
2/16/2024
0
 
 
 
Menlo Microsystems Inc Series C
2/9/2022
5,863,333
 
 
 
Menlo Microsystems Inc Series C-1
4/17/2026
125,074
 
 
 
Mentari Therapeutics Inc Series A
9/18/2025
2,751,822
 
 
 
Mirador Therapeutics Inc Series A
3/19/2024
8,034,735
 
 
 
Mirador Therapeutics Inc Series B
7/31/2025
9,709,323
 
 
 
National Resilience LLC Series B
12/1/2020
17,448,533
 
 
 
National Resilience LLC Series C
6/28/2021
16,831,390
 
 
 
Neurona Therapeutics Inc
6/1/2026
98,916
 
 
 
Neurona Therapeutics Inc
6/1/2026
0
 
 
 
Neurona Therapeutics Inc escrow shares
6/1/2026
494,580
 
 
 
Neurona Therapeutics Inc milestone 2 rights
6/1/2026
32,972
 
 
 
Neurona Therapeutics Inc milestone 3 rights
6/1/2026
32,972
 
 
 
Neurona Therapeutics Inc milestone 4 rights
6/1/2026
32,972
 
 
 
Neutron Holdings Inc
1/25/2019 - 4/27/2026
18,384,097
 
 
 
Nscale Limited Series B
9/25/2025
6,723,876
 
 
 
OpenAI Group Pbc Class A
9/3/2025
7,740,000
 
 
 
OpenAI Group Pbc Series A-3
8/4/2025
7,051,600
 
 
 
Oura Inc Series D
12/18/2024
22,207,129
 
 
 
Oura Inc Series E
9/24/2025
102,899,667
 
 
 
Paragon Biosciences Emalex Capital Inc Adjustment Escrow
6/10/2026
109,549
 
 
 
Paragon Biosciences Emalex Capital Inc Milestone 1 June 10, 2028
6/10/2026
1,884,246
 
 
 
Paragon Biosciences Emalex Capital Inc Milestone 2
6/10/2026
416,287
 
 
 
Paragon Biosciences Emalex Capital Inc ODT Royalty
6/10/2026
0
 
 
 
Paragon Biosciences Emalex Capital Inc Ombakay Royalty
6/10/2026
854,484
 
 
 
Paragon Biosciences Emalex Capital Inc Priority Review Voucher Sale
6/10/2026
0
 
 
 
Physical Intelligence Inc Series B
10/24/2025
11,324,023
 
 
 
Physical Intelligence Inc Series C
5/28/2026
2,204,231
 
 
 
Prognomiq Inc
8/20/2020 - 2/16/2022
3,655,328
 
 
 
Quell Therapeutics Ltd Series B
11/24/2021
7,315,491
 
 
 
Rad Power Bikes Inc
1/21/2021
5,704,519
 
 
 
Rad Power Bikes Inc 8% 12/31/2199
10/6/2023
985,838
 
 
 
Rad Power Bikes Inc Series A
1/21/2021
743,711
 
 
 
Rad Power Bikes Inc Series C
1/21/2021
2,926,421
 
 
 
Rad Power Bikes Inc Series D
9/17/2021
10,267,125
 
 
 
Rad Power Bikes Inc warrants 10/6/2033
10/6/2023
1
 
 
 
Redwood Materials Series C
5/28/2021
3,794,980
 
 
 
Redwood Materials Series D
6/2/2023
895,095
 
 
 
Redwood Materials Series E
10/20/2025
243,022
 
 
 
Retym Inc Series C
5/17/2023 - 6/20/2023
5,184,951
 
 
 
Retym Inc Series D
1/29/2025
1,749,936
 
 
 
Revolut Group Holdings Ltd
12/27/2024 - 1/28/2026
15,454,253
 
 
 
Sail Biomedicines Series B
8/13/2021
6,040,824
 
 
 
Saluda Medical Inc
1/20/2022 - 10/30/2025
15,689,219
 
 
 
Saluda Medical Inc warrants
1/20/2022
0
 
 
 
Scorpion Therapeutics Inc
3/5/2025
0
 
 
 
Scorpion Therapeutics Inc rights
3/5/2025
1,391,599
 
 
 
Serif Biomedicines, Inc
3/31/2026
8,734,681
 
 
 
SiMa Technologies Inc Series B
5/10/2021
8,184,439
 
 
 
SiMa Technologies Inc Series B1
4/25/2022
758,173
 
 
 
SiMa Technologies Inc Series C
4/8/2024 - 8/18/2026
7,211,906
 
 
 
SkinHealth Systems Inc
12/8/2020
24,388,170
 
 
 
Skyhawk Therapeutics Inc
12/19/2019 - 5/21/2021
22,650,905
 
 
 
Skyhawk Therapeutics Inc rights 5/23/2028
12/19/2019
0
 
 
 
Skyryse Inc Series B
10/21/2021
14,029,206
 
 
 
Skyryse Inc Series C
9/16/2025 - 11/21/2025
8,015,486
 
 
 
Skyryse Inc Series C-1
8/13/2024
1,093,997
 
 
 
Sonoma Biotherapeutics Inc Series B
7/26/2021
4,936,323
 
 
 
Sonoma Biotherapeutics Inc Series B1
7/26/2021
3,949,058
 
 
 
Souffle Therapeutics Inc Series B
7/22/2026
6,773,683
 
 
 
Stripe Global Holdings Inc
5/18/2021
8,246,382
 
 
 
Stripe Global Holdings Inc Series H
3/15/2021
3,539,025
 
 
 
T-Knife Therapeutics Inc Series B
6/30/2021
5,740,908
 
 
 
Taalas Inc 0%
12/23/2025
8,759,878
 
 
 
Taalas Inc Series B
2/19/2025
5,266,195
 
 
 
Taalas Inc warrants
12/23/2025
1,768,822
 
 
 
Tenstorrent Holdings Inc 15% 12/31/2026
2/25/2026
5,437,296
 
 
 
Tenstorrent Holdings Inc Series C1
4/23/2021
10,595,741
 
 
 
Tenstorrent Holdings Inc Series D1
7/16/2024 - 1/15/2025
14,112,772
 
 
 
Tenstorrent Holdings Inc Series D2
7/17/2024
3,590,207
 
 
 
Tory Burch LLC Class A
5/14/2015
65,871,826
 
 
 
Tory Burch LLC Class B
12/31/2012
17,170,277
 
 
 
Treeline Biosciences Series A
7/30/2021 - 10/27/2022
10,545,678
 
 
 
Treeline Biosciences Series A1
10/27/2022
3,997,039
 
 
 
Triveni Bio Inc Series B
9/19/2024
4,987,164
 
 
 
Triveni Bio Inc Series C
5/28/2026
1,994,865
 
 
 
Tubulis GmbH escrow shares
5/21/2026
144
 
 
 
Tubulis GmbH escrow shares
5/21/2026
24,912
 
 
 
Tubulis GmbH milestone 1 rights
5/21/2026
506,520
 
 
 
Tubulis GmbH milestone 10 rights
5/21/2026
15,984
 
 
 
Tubulis GmbH milestone 11 rights
5/21/2026
15,120
 
 
 
Tubulis GmbH milestone 2 rights
5/21/2026
769,032
 
 
 
Tubulis GmbH milestone 3 rights
5/21/2026
344,376
 
 
 
Tubulis GmbH milestone 4 rights
5/21/2026
401,328
 
 
 
Tubulis GmbH milestone 5 rights
5/21/2026
67,176
 
 
 
Tubulis GmbH milestone 6 rights
5/21/2026
211,680
 
 
 
Tubulis GmbH milestone 7 rights
5/21/2026
206,280
 
 
 
Tubulis GmbH milestone 8 rights
5/21/2026
33,552
 
 
 
Tubulis GmbH milestone 9 rights
5/21/2026
33,552
 
 
 
Valuedrive Technologies Pvt Ltd Series A
2/12/2026
436,197
 
 
 
Valuedrive Technologies Pvt Ltd Series B
2/12/2026
876,359
 
 
 
Valuedrive Technologies Pvt Ltd Series C
2/12/2026
3,604
 
 
 
Valuedrive Technologies Pvt Ltd Series C1
2/12/2026
2,403
 
 
 
Valuedrive Technologies Pvt Ltd Series G
2/12/2026
1,771,543
 
 
 
Valuedrive Technologies Pvt Ltd Series S2
2/12/2026
193,424
 
 
 
Vast Data Ltd Series A
11/28/2023
3,500,431
 
 
 
Vast Data Ltd Series A1
11/28/2023
8,615,728
 
 
 
Vast Data Ltd Series A2
11/28/2023
9,910,835
 
 
 
Vast Data Ltd Series B
11/28/2023
7,886,175
 
 
 
Vast Data Ltd Series C
11/28/2023
229,889
 
 
 
Vast Data Ltd Series E
11/28/2023
15,071,540
 
 
 
Waymo LLC Series A2
5/8/2020
3,844,017
 
 
 
Waymo LLC Series C2
10/18/2024
2,623,966
 
 
 
Xsight Labs Ltd Series D
2/16/2021
6,299,753
 
 
 
Xsight Labs Ltd Series F
1/11/2024 - 12/30/2024
6,035,057
 
 
 
Xsight Labs Ltd Series G
5/7/2026 - 7/10/2026
4,220,104
 
 
 
Xsight Labs Ltd warrants 7/24/2032
1/11/2024 - 12/30/2024
0
 
 
 
Zipline International Inc Series G
6/7/2024
7,552,977
 
 
 
Zipline International Inc Series H
12/3/2025
17,318,139
 
 
 
Additional information on each lock-up restriction is as follows:
Security
Restriction Expiration Date
Bending Spoons SpA
12/28/2026
 
 
Cerebras Systems Inc B - 180 Day Lockup Final Release
11/9/2026
 
 
Cerebras Systems Inc B - October 14, 2026 Lockup Release
10/14/2026
 
 
Cerebras Systems Inc B - October 28, 2026 Lockup Release
10/28/2026
 
 
Cerebras Systems Inc B - September 16, 2026 Lockup Release
9/16/2026
 
 
Cerebras Systems Inc B - September 2, 2026 Lockup Release
9/2/2026
 
 
Cerebras Systems Inc B - September 30, 2026 Lockup Release
9/30/2026
 
 
Kardigan Inc
12/15/2026
 
 
Neutron Holdings Inc
12/30/2026
 
 
Odyssey Therapeutics Inc
11/4/2026
 
 
Parabilis Medicines Inc
12/7/2026
 
 
Parabilis Medicines Inc
12/7/2026
 
 
Saluda Medical Inc
3/31/2027
 
 
Saluda Medical Inc warrants
3/31/2027
 
 
Space Exploration Technologies Corp
12/8/2026
 
 
Space Exploration Technologies Corp - 180 Day Lockup Final Release
12/8/2026
 
 
Space Exploration Technologies Corp - October 24, 2026 Lockup Release
10/24/2026
 
 
Space Exploration Technologies Corp - October 9, 2026 Lockup Release
10/9/2026
 
 
Space Exploration Technologies Corp - Q3 2026 Earnings Release Lockup
11/9/2026
 
 
Space Exploration Technologies Corp - September 24, 2026 Lockup Release
9/24/2026
 
 
Space Exploration Technologies Corp - September 9, 2026 Lockup Release
9/9/2026
 
 
 
Affiliated Underlying Funds
Fiscal year to date information regarding the Fund's investments in affiliated underlying funds is presented below. Exchanges between classes of the same affiliated underlying funds may occur. If an underlying fund changes its name, the name presented below is the name in effect at period end.
Affiliate
Value,
beginning
of period ($)
Purchases ($)
Sales
Proceeds ($)
Dividend
Income ($)
Realized
Gain (loss) ($)
Change in
Unrealized
appreciation
(depreciation) ($)
Value,
end
of period ($)
 
 
Shares,
end
of period
Fidelity Cash Central Fund
270,128,286
3,260,170,061
3,362,612,570
4,874,894
(6,478)
4,568
167,683,867
167,650,337
Fidelity Securities Lending Cash Central Fund
230,381,208
2,861,592,137
2,548,615,664
2,582,104
165
-
543,357,846
543,303,516
 
500,509,494
6,121,762,198
5,911,228,234
7,456,998
(6,313)
4,568
711,041,713
 
 
Amounts in the dividend income column in the above table include any capital gain distributions from underlying funds.
Amounts in the dividend income column for Fidelity Securities Lending Cash Central Fund represents the income earned on investing cash collateral, less rebates paid to borrowers and any lending agent fees associated with the loan, plus any premium income received for lending certain types of securities.
 
Other Affiliated Issuers
An affiliated company is a company in which the Fund has ownership of at least 5% of the voting securities. Fiscal year to date transactions with companies which are or were affiliates are presented in the table below. Certain corporate actions, such as mergers, are excluded from the amounts in this table if applicable. A dash in the Value end of period ($) column means either the issuer is no longer held at period end, or the issuer is held at period end but is no longer an affiliate.
Affiliate
Value,
beginning
of period ($)
Purchases ($)
Sales
Proceeds ($)
Dividend
Income ($)
Realized
Gain (loss) ($)
Change in
Unrealized
appreciation
(depreciation) ($)
Value,
end
of period ($)
 
 
Shares,
end
of period
Beauty Health Co/The Class A
5,613,103
4,846,061
3,499,255
-
(14,611,871)
7,651,962
-
-
Cyclerion Therapeutics Inc
-
1,414,500
909
-
(753)
(610,642)
802,196
217,988
Everpure Inc Class A
1,420,681,859
84,226,518
7,717,949
-
5,759,585
85,076,105
1,588,026,118
17,084,735
InMed Pharmaceuticals Inc
-
15,616,619
-
-
-
2,230,519
17,847,138
6,610,051
Ionis Pharmaceuticals Inc
674,716,759
30,872,492
4,532,019
-
3,464,542
(191,241,158)
513,280,616
8,503,655
Korsana Biosciences
-
8,916,715
-
-
-
7,937,867
16,854,582
3,770,600
Nektar Therapeutics
-
120,186,447
145,602
-
64,669
11,981,606
132,087,120
1,850,478
Novocure Ltd
69,646,177
6,332,388
493,043
-
(15,932)
28,215,264
103,684,854
5,874,496
Nutanix Inc Class A
642,510,057
39,419,511
13,250,423
-
(6,360,092)
286,970,335
949,289,388
13,844,092
Nuvation Bio Inc Class A
135,702,214
4,770,709
977,708
-
867,114
(22,497,552)
117,864,777
17,697,414
SkinHealth Systems Inc
4,269,381
-
4,459,000
-
-
1,838,502
-
-
Total
2,953,139,550
316,601,960
35,075,908
-
(10,832,738)
217,552,808
3,439,736,789
 
 
 
 
Investment Valuation
Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Securities transactions are accounted for as of trade date. The Board of Trustees (the Board) has designated the Fund's investment adviser as the valuation designee responsible for the fair valuation function and performing fair value determinations as needed. The investment adviser has established a Fair Value Committee (the Committee) to carry out the day-to-day fair valuation responsibilities and has adopted policies and procedures to govern the fair valuation process and the activities of the Committee. In accordance with these fair valuation policies and procedures, which have been approved by the Board, the Fund attempts to obtain prices from one or more third party pricing services or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with the policies and procedures. Factors used in determining fair value vary by investment type and may include market or investment specific events, transaction data, estimated cash flows, and market observations of comparable investments. The frequency that the fair valuation procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee manages the Fund's fair valuation practices and maintains the fair valuation policies and procedures. The Fund's investment adviser reports to the Board information regarding the fair valuation process and related material matters.   
 
The inputs to valuation techniques used to value investments are categorized into a disclosure hierarchy consisting of three levels as shown below:
 
Level 1 - Unadjusted quoted prices in active markets for identical investments
Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, etc.)
Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available)
 
Valuation techniques used to value investments by major category are as follows:
Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing service on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For any foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy.
 
Securities, including private placements or other restricted securities, for which observable inputs are not available are valued using alternate valuation approaches, including the market approach, the income approach and cost approach, and are categorized as Level 3 in the hierarchy. The market approach considers factors including the price of recent investments in the same or a similar security or financial metrics of comparable securities. The income approach considers factors including expected future cash flows, security specific risks and corresponding discount rates. The cost approach considers factors including the value of the security's underlying assets and liabilities.
 
Debt securities, including restricted securities, are valued based on evaluated prices received from third party pricing services or from brokers who make markets in such securities. Convertible Corporate Bonds and Preferred Securities are valued by pricing services who utilize matrix pricing which considers yield or price of bonds of comparable quality, coupon, maturity and type or by broker-supplied prices. When independent prices are unavailable or unreliable, debt securities may be valued utilizing pricing methodologies which consider similar factors that would be used by third party pricing services. Debt securities are generally categorized as Level 2 in the hierarchy but may be Level 3 depending on the circumstances.
 
Investments in any open-end mutual funds are valued at their closing net asset value (NAV) each business day and are categorized as Level 1 in the hierarchy.
 
Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy.
 
For additional information on the Fund's significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.
 
 
 
The fund's consolidated schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please see the fund's most recent prospectus and annual report.
 
Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.